Media formats available:
Recommended
- Tackling residual risk beyond LDL-c therapy: The emerging role of EPA & triglyceridesWhat is the evidence of EPA-based therapy for CV prevention?
Prof. Lale Tokgözoğlu, MD
- Tackling residual risk beyond LDL-c therapy: The emerging role of EPA & triglyceridesUnravelling the triglyceride story
prof. Paul Ridker, MD